BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buscarini L, Buscarini E, Di Stasi M, Quaretti P, Zangrandi A. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med. 1999;20:47-53. [PMID: 10407974 DOI: 10.1055/s-1999-14233] [Cited by in Crossref: 94] [Cited by in F6Publishing: 79] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Sheta E, El-kalla F, El-gharib M, Kobtan A, Elhendawy M, Abd-elsalam S, Mansour L, Amer I. Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled study. European Journal of Gastroenterology & Hepatology 2016;28:1198-203. [DOI: 10.1097/meg.0000000000000688] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
2 Ni J, Liu S, Xu L, Sun H, Chen Y. Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 2013;139:653-9. [DOI: 10.1007/s00432-012-1369-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
3 Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2013;19:3872-82. [PMID: 23840128 DOI: 10.3748/wjg.v19.i24.3872] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 80] [Article Influence: 13.1] [Reference Citation Analysis]
4 Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti SK. Percutaneous tumor ablation with radiofrequency. Cancer 2002;94:443-51. [PMID: 11900230 DOI: 10.1002/cncr.10234] [Cited by in Crossref: 115] [Cited by in F6Publishing: 80] [Article Influence: 6.1] [Reference Citation Analysis]
5 Arii S, Sata M, Sakamoto M, Shimada M, Kumada T, Shiina S, Yamashita T, Kokudo N, Tanaka M, Takayama T, Kudo M. Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res. 2010;40:667-685. [PMID: 20633193 DOI: 10.1111/j.1872-034x.2010.00673.x] [Cited by in Crossref: 129] [Cited by in F6Publishing: 45] [Article Influence: 12.9] [Reference Citation Analysis]
6 Azuma S, Asahina Y, Nishimura-sakurai Y, Kakinuma S, Kaneko S, Nagata H, Goto F, Ootani S, Kawai-kitahata F, Taniguchi M, Murakawa M, Watanabe T, Tasaka-fujita M, Itsui Y, Nakagawa M, Watanabe M. Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma: Additional RFA after TACE for intermediate HCC. Hepatol Res 2016;46:312-9. [DOI: 10.1111/hepr.12566] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
7 Yamagami T, Nakamura T, Kato T, Matsushima S, Iida S, Nishimura T. Skin injury after radiofrequency ablation for hepatic cancer. AJR Am J Roentgenol. 2002;178:905-907. [PMID: 11906870 DOI: 10.2214/ajr.178.4.1780905] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
8 Kurokohchi K, Watanabe S, Masaki T, Hosomi N, Miyauchi Y, Himoto T, Kimura Y, Nakai S, Deguchi A, Yoneyama H, Yoshida S, Kuriyama S. Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma. World J Gastroenterol 2005;11:1426-32. [PMID: 15770716 DOI: 10.3748/wjg.v11.i10.1426] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
9 Lee JM, Youk JH, Kim YK, Han YM, Chung GH, Lee SY, Kim CS. Radio-frequency thermal ablation with hypertonic saline solution injection of the lung: ex vivo and in vivo feasibility studies. Eur Radiol 2003;13:2540-7. [PMID: 12707797 DOI: 10.1007/s00330-003-1876-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
10 Xu LF, Sun HL, Chen YT, Ni JY, Chen D, Luo JH, Zhou JX, Hu RM, Tan QY. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. J Gastroenterol Hepatol. 2013;28:456-463. [PMID: 23216261 DOI: 10.1111/jgh.12088] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
11 Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS. Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone. Qual Life Res. 2007;16:389-397. [PMID: 17111232 DOI: 10.1007/s11136-006-9133-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
12 Murakami T, Ishimaru H, Sakamoto I, Uetani M, Matsuoka Y, Daikoku M, Honda S, Koshiishi T, Fujimoto T. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Cardiovasc Intervent Radiol. 2007;30:696-704. [PMID: 17497071 DOI: 10.1007/s00270-007-9003-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
13 Xie L, Cao F, Qi H, Song Z, Shen L, Chen S, Hu Y, Chen C, Fan W. Efficacy and safety of CT-guided percutaneous thermal ablation for hepatocellular carcinoma adjacent to the second porta hepatis. International Journal of Hyperthermia 2019;36:1121-7. [DOI: 10.1080/02656736.2019.1684575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zangos S, Eichler K, Balzer JO, Straub R, Hammerstingl R, Herzog C, Lehnert T, Heller M, Thalhammer A, Mack MG, Vogl TJ. Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol 2007;17:553-63. [PMID: 16896704 DOI: 10.1007/s00330-006-0343-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
15 Gazelle GS, Mcmahon PM, Beinfeld MT, Halpern EF, Weinstein MC. Metastatic Colorectal Carcinoma: Cost-effectiveness of Percutaneous Radiofrequency Ablation versus That of Hepatic Resection. Radiology 2004;233:729-39. [DOI: 10.1148/radiol.2333032052] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
16 Tan T, Shen Z, Wang Y, Guo Z, Hu J, Zhang Y. Self-assembly of pentapeptides in ethanol to develop organogels. Soft Matter 2020;16:10567-73. [DOI: 10.1039/d0sm01303j] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Buscarini E, Savoia A, Brambilla G, Menozzi F, Reduzzi L, Strobel D, Hänsler J, Buscarini L, Gaiti L, Zambelli A. Radiofrequency thermal ablation of liver tumors. Eur Radiol. 2005;15:884-894. [PMID: 15754165 DOI: 10.1007/s00330-005-2652-x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
18 Grasso A, Watkinson AF, Tibballs JM, Burroughs AK. Radiofrequency ablation in the treatment of hepatocellular carcinoma--a clinical viewpoint. J Hepatol. 2000;33:667-672. [PMID: 11059876 DOI: 10.1016/s0168-8278(00)80023-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
19 Seki T, Tamai T, Ikeda K, Imamura M, Nishimura A, Yamashiki N, Nakagawa T, Inoue K. Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region: . European Journal of Gastroenterology & Hepatology 2001;13:291-4. [DOI: 10.1097/00042737-200103000-00014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
20 Ashoori N, Paprottka P, Trumm C, Bamberg F, Kolligs FT, Rentsch M, Reiser MF, Jakobs TF. Multimodality treatment with conventional transcatheter arterial chemoembolization and radiofrequency ablation for unresectable hepatocellular carcinoma. Digestion. 2012;85:18-26. [PMID: 22156507 DOI: 10.1159/000334714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
21 Liao GS, Yu CY, Shih ML, Chan DC, Liu YC, Yu JC, Chen TW, Hsieh CB. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. Eur J Surg Oncol. 2008;34:61-66. [PMID: 17434711 DOI: 10.1016/j.ejso.2007.02.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
22 Lu DS, Raman SS, Limanond P, Aziz D, Economou J, Busuttil R, Sayre J. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol. 2003;14:1267-1274. [PMID: 14551273 DOI: 10.1097/01.rvi.0000092666.72261.6b] [Cited by in Crossref: 318] [Cited by in F6Publishing: 110] [Article Influence: 18.7] [Reference Citation Analysis]
23 Miyayama S, Matsui O, Nishida H, Yamamori S, Minami T, Shinmura R, Kozaka K, Notsumata K, Toya D, Tanaka N. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma fed by the cystic artery. J Vasc Interv Radiol. 2003;14:1155-1161. [PMID: 14514807 DOI: 10.1097/01.RVI.0000086534.86489.10] [Cited by in Crossref: 36] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
24 Hoffer FA. Interventional radiology in pediatric oncology. European Journal of Radiology 2005;53:3-13. [DOI: 10.1016/j.ejrad.2004.07.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
25 Nakai M, Sato M, Sahara S, Kawai N, Tanihata H, Kimura M, Terada M. Radiofrequency ablation in a porcine liver model: effects of transcatheter arterial embolization with iodized oil on ablation time, maximum output, and coagulation diameter as well as angiographic characteristics. World J Gastroenterol 2007;13:2841-5. [PMID: 17569120 DOI: 10.3748/wjg.v13.i20.2841] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
26 Takaki H, Yamakado K, Uraki J, Nakatsuka A, Fuke H, Yamamoto N, Shiraki K, Yamada T, Takeda K. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol. 2009;20:217-224. [PMID: 19097810 DOI: 10.1016/j.jvir.2008.10.019] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
27 Kitamoto M, Imagawa M, Yamada H, Watanabe C, Sumioka M, Satoh O, Shimamoto M, Kodama M, Kimura S, Kishimoto K. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol. 2003;181:997-1003. [PMID: 14500217 DOI: 10.2214/ajr.181.4.1810997] [Cited by in Crossref: 75] [Cited by in F6Publishing: 66] [Article Influence: 4.2] [Reference Citation Analysis]
28 Ham SJ, Choi Y, Lee SI, Kim J, Kim YI, Chung JW, Kim KW. Enhanced efficacy of radiofrequency ablation for hepatocellular carcinoma using a novel vascular disrupting agent, CKD-516. Hepatol Int 2017;11:446-51. [PMID: 28721452 DOI: 10.1007/s12072-017-9811-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yamakado K, Nakatsuka A, Ohmori S, Shiraki K, Nakano T, Ikoma J, Adachi Y, Takeda K. Radiofrequency Ablation Combined with Chemoembolization in Hepatocellular Carcinoma: Treatment Response Based on Tumor Size and Morphology. Journal of Vascular and Interventional Radiology 2002;13:1225-32. [DOI: 10.1016/s1051-0443(07)61969-1] [Cited by in Crossref: 153] [Cited by in F6Publishing: 37] [Article Influence: 8.1] [Reference Citation Analysis]
30 Gebauer B, Werk M, Lopez-hänninen E, Felix R, Althaus P. Radiofrequency Ablation in Combination with Embolization in Metachronous Recurrent Renal Cancer in Solitary Kidney after Contralateral Tumor Nephrectomy. Cardiovasc Intervent Radiol 2007;30:644-9. [DOI: 10.1007/s00270-007-9012-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
31 Pleguezuelo M, Marelli L, Misseri M, Germani G, Calvaruso V, Xiruochakis E, Pinelopi M, Burroughs AK. TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther. 2008;8:1623-1641. [PMID: 18925854 DOI: 10.1586/14737140.8.10.1623] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
32 Buscarini L, Buscarini E. Radiofrequency Thermal Ablation of Hepatocellular Carcinoma. In: Habib NA, editor. Multi-Treatment Modalities of Liver Tumours. Boston: Springer US; 2002. pp. 119-29. [DOI: 10.1007/978-1-4615-0547-1_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, Kohara K, Shigenobu S, Ishibashi K, Arima T. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97:1253-1262. [PMID: 12599233 DOI: 10.1002/cncr.11168] [Cited by in Crossref: 239] [Cited by in F6Publishing: 207] [Article Influence: 13.3] [Reference Citation Analysis]
34 Galanakis N, Kehagias E, Matthaiou N, Samonakis D, Tsetis D. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review. Hepat Oncol 2018;5:HEP07. [PMID: 31293775 DOI: 10.2217/hep-2018-0001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Goldberg SN, Ahmed M. Minimally invasive image-guided therapies for hepatocellular carcinoma. J Clin Gastroenterol 2002;35:S115-29. [PMID: 12394215 DOI: 10.1097/00004836-200211002-00008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
36 Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol. 2004;5:550-560. [PMID: 15337485 DOI: 10.1016/s1470-2045(04)01567-0] [Cited by in Crossref: 135] [Cited by in F6Publishing: 30] [Article Influence: 7.9] [Reference Citation Analysis]
37 Zhang L, Yin X, Gan YH, Zhang BH, Zhang JB, Chen Y, Xie XY, Ge NL, Wang YH, Ye SL. Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria. BMC Gastroenterol. 2014;14:11. [PMID: 24410841 DOI: 10.1186/1471-230x-14-11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
38 Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology. 2000;217:633-646. [PMID: 11110923 DOI: 10.1148/radiology.217.3.r00dc26633] [Cited by in Crossref: 538] [Cited by in F6Publishing: 446] [Article Influence: 26.9] [Reference Citation Analysis]
39 Kurokohchi K, Deguchi A, Masaki T, Himoto T, Yoneyama H, Kobayashi M, Maeta T, Kiuchi T, Kohi F, Miyoshi H, Taminato T, Kuriyama S. Successful treatment of hypovascular advanced hepatocellular carcinoma with lipiodol-targetting intervention radiology. World J Gastroenterol 2007;13:4398-400. [PMID: 17708619 DOI: 10.3748/wjg.v13.i32.4398] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
40 Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable primary liver cancer. J Am Coll Surg. 2002;194:813-828; discussion 828. [PMID: 12081073 DOI: 10.1016/s1072-7515(02)01180-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
41 Shirato K, Morimoto M, Tomita N, Kokawa A, Sugimori K, Saito T, Numata K, Sekihara H, Tanaka K. Hepatocellular Carcinoma: Therapeutic Experience With Percutaneous Ethanol Injection Under Real-time Contrast-Enhanced Color Doppler Sonography With the Contrast Agent Levovist. Journal of Ultrasound in Medicine 2002;21:1015-22. [DOI: 10.7863/jum.2002.21.9.1015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
42 Barakat O, Wood RP, Ozaki CF, Ankoma-Sey V, Galati J, Skolkin M, Toombs B, Round M, Moore W, Mieles L. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis. Liver Transpl. 2010;16:289-299. [PMID: 20209588 DOI: 10.1002/lt.21994] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
43 Xu HX, Xie XY, Lu MD, Chen JW, Yin XY, Xu ZF, Liu GJ. Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clin Radiol. 2004;59:53-61. [PMID: 14697375 DOI: 10.1016/j.crad.2003.09.006] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 4.5] [Reference Citation Analysis]
44 Shirato K, Morimoto M, Tomita N, Kokawa A, Sugimori K, Saito T, Numata K, Sekihara H, Tanaka K. Small Hepatocellular Carcinoma: Therapeutic Effectiveness of Percutaneous Radio Frequency Ablation Therapy With a LeVeen Needle Electrode. Journal of Ultrasound in Medicine 2002;21:67-76. [DOI: 10.7863/jum.2002.21.1.67] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
45 Machi J, Bueno RS, Wong LL. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg. 2005;29:1364-1373. [PMID: 16240062 DOI: 10.1007/s00268-005-7829-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
46 Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 2010;116:5452-60. [DOI: 10.1002/cncr.25314] [Cited by in Crossref: 187] [Cited by in F6Publishing: 166] [Article Influence: 17.0] [Reference Citation Analysis]
47 Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002;235:466-86. [PMID: 11923602 DOI: 10.1097/00000658-200204000-00004] [Cited by in Crossref: 300] [Cited by in F6Publishing: 269] [Article Influence: 15.8] [Reference Citation Analysis]
48 Yang W, Chen MH, Wang MQ, Cui M, Gao W, Wu W, Wu JY, Dai Y, Yan K. Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. Hepatol Res 2009;39:231-40. [PMID: 19054154 DOI: 10.1111/j.1872-034X.2008.00451.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
49 Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M. Percutaneous radiofrequency ablation for hepatocellular carcinoma: An analysis of 1000 cases. Cancer 2005;103:1201-9. [DOI: 10.1002/cncr.20892] [Cited by in Crossref: 553] [Cited by in F6Publishing: 485] [Article Influence: 34.6] [Reference Citation Analysis]
50 Chen MH, Yang W, Yan K, Zou MW, Solbiati L, Liu JB, Dai Y. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process. Radiology. 2004;232:260-271. [PMID: 15166323 DOI: 10.1148/radiol.2321030821] [Cited by in Crossref: 169] [Cited by in F6Publishing: 143] [Article Influence: 9.9] [Reference Citation Analysis]
51 Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158-171. [PMID: 16041205 DOI: 10.1097/01.sla.0000171032.99149.fe] [Cited by in Crossref: 503] [Cited by in F6Publishing: 432] [Article Influence: 31.4] [Reference Citation Analysis]
52 Yi Y, Zhang Y, Wei Q, Zhao L, Han J, Song Y, Ding Y, Lu G, Liu J, Ding H, Dai F, Tang X. Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone. Chin J Cancer Res 2014;26:112-8. [PMID: 24653633 DOI: 10.3978/j.issn.1000-9604.2014.02.09] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
53 Buscarini E, Buscarini L. Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report. Eur Radiol. 2004;14:31-37. [PMID: 14564470 DOI: 10.1007/s00330-003-1990-9] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
54 Smith MT, Ray CE. The treatment of primary and metastatic hepatic neoplasms using percutaneous cryotherapy. Semin Intervent Radiol. 2006;23:39-46. [PMID: 21326719 DOI: 10.1055/s-2006-939840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
55 Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X, Ling C. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study. Cancer. 2009;115:5132-5138. [PMID: 19672999 DOI: 10.1002/cncr.24567] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
56 McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol. 2001;176:3-16. [PMID: 11133529 DOI: 10.2214/ajr.176.1.1760003] [Cited by in Crossref: 460] [Cited by in F6Publishing: 359] [Article Influence: 23.0] [Reference Citation Analysis]
57 Morishita A, Sakamoto T, Kobara H, Tadokoro T, Ohura K, Fujita K, Tani J, Miyoshi H, Yoneyama H, Himoto T, Masaki T. Evaluation of in vivo efficacy of radiofrequency ablation with D-sorbitol in animal liver. Mol Clin Oncol 2016;4:183-6. [PMID: 26893857 DOI: 10.3892/mco.2015.680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 Qian J, Feng GS, Vogl T. Combined interventional therapies of hepatocellular carcinoma. World J Gastroenterol. 2003;9:1885-1891. [PMID: 12970869 DOI: 10.3748/wjg.v9.i9.1885] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
59 Nakasone Y, Kawanaka K, Ikeda O, Tamura Y, Yamashita Y. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study. Acta Radiol 2012;53:410-4. [PMID: 22393159 DOI: 10.1258/ar.2012.110413] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
60 Liu Z, Ahmed M, Sabir A, Humphries S, Goldberg SN. Computer modeling of the effect of perfusion on heating patterns in radiofrequency tumor ablation. Int J Hyperthermia 2007;23:49-58. [PMID: 17575723 DOI: 10.1080/02656730601094415] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
61 Ahmed M, Weinstein J, Liu Z, Afzal KS, Horkan C, Kruskal JB, Goldberg SN. Image-guided percutaneous chemical and radiofrequency tumor ablation in an animal model. J Vasc Interv Radiol 2003;14:1045-52. [PMID: 12902563 DOI: 10.1097/01.rvi.0000083254.29749.e1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
62 Chen MH, Yang W, Yan K, Gao W, Dai Y, Wang YB, Zhang XP, Yin SS. Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol. 2005;11:6395-6401. [PMID: 16419172 DOI: 10.3748/wjg.v11.i40.6395] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
63 Yin X, Zhang L, Wang YH, Zhang BH, Gan YH, Ge NL, Chen Y, Li LX, Ren ZG. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma. BMC Cancer. 2014;14:849. [PMID: 25409554 DOI: 10.1186/1471-2407-14-849] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
64 Goletti O, Lencioni R, Armillotta N, Puglisi A, Lippolis PV, Lorenzetti L, Cioni D, Musco B, Bartolozzi C, Cavina E. Laparoscopic Radiofrequency Thermal Ablation of Hepatocarcinoma: Preliminary Experience: . Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2000;10:284-90. [DOI: 10.1097/00129689-200010000-00005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
65 Seong NJ, Yoon CJ, Kang SG, Chung JW, Kim HC, Park JH. Effects of arsenic trioxide on radiofrequency ablation of VX2 liver tumor: intraarterial versus intravenous administration. Korean J Radiol 2012;13:195-201. [PMID: 22438687 DOI: 10.3348/kjr.2012.13.2.195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
66 Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach”. Cancer. 2003;97:3027-3035. [PMID: 12784338 DOI: 10.1002/cncr.11426] [Cited by in Crossref: 222] [Cited by in F6Publishing: 182] [Article Influence: 12.3] [Reference Citation Analysis]
67 Ng KK, Lam CM, Poon RT, Ai V, Tso WK, Fan ST. Thermal ablative therapy for malignant liver tumors: a critical appraisal. J Gastroenterol Hepatol. 2003;18:616-629. [PMID: 12753142 DOI: 10.1046/j.1440-1746.2003.02991.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
68 Vallone P, Catalano O, Izzo F, Siani A. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Cardiovasc Intervent Radiol 2006;29:544-51. [PMID: 16528626 DOI: 10.1007/s00270-005-0173-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
69 Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Fukushima N, Sakamoto M. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer. 2002;95:1931-1937. [PMID: 12404287 DOI: 10.1002/cncr.10892] [Cited by in Crossref: 145] [Cited by in F6Publishing: 135] [Article Influence: 7.6] [Reference Citation Analysis]
70 Kudo K, Moriyasu F, Mine Y, Miyata Y, Sugimoto K, Metoki R, Kamamoto H, Suzuki S, Shimizu M, Miyahara T, Yokoi M, Horibe T, Yamagata H. Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system. European Journal of Radiology 2007;61:324-31. [DOI: 10.1016/j.ejrad.2006.09.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
71 Cheung TT, Ma KW, She WH. A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis. Hepatobiliary Surg Nutr 2021;10:193-209. [PMID: 33898560 DOI: 10.21037/hbsn.2020.03.11] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Zhang Y, Liang H, Chen M, Guo R, Li J, Zheng Y, Zhang Y, Lau WY. Hepatocellular Carcinoma Treated with Radiofrequency Ablation with or without Ethanol Injection: A Prospective Randomized Trial. Radiology 2007;244:599-607. [DOI: 10.1148/radiol.2442060826] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 7.4] [Reference Citation Analysis]
73 Yamakado K, Nakatsuka A, Kobayashi S, Akeboshi M, Takaki H, Kariya Z, Kinbara H, Arima K, Yanagawa M, Hori Y, Kato H, Sugimura Y, Takeda K. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience. Cardiovasc Intervent Radiol 2006;29:389-94. [PMID: 16502180 DOI: 10.1007/s00270-004-0090-9] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
74 Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. 2006;16:661-669. [PMID: 16228211 DOI: 10.1007/s00330-005-0029-9] [Cited by in Crossref: 155] [Cited by in F6Publishing: 145] [Article Influence: 9.7] [Reference Citation Analysis]
75 Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, De Wever I, Michel L. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;89:1206-1222. [PMID: 12296886 DOI: 10.1046/j.1365-2168.2002.02168.x] [Cited by in Crossref: 529] [Cited by in F6Publishing: 429] [Article Influence: 27.8] [Reference Citation Analysis]
76 Ahmed M, Goldberg SN. Thermal ablation therapy for hepatocellular carcinoma. J Vasc Interv Radiol 2002;13:S231-44. [PMID: 12354841 DOI: 10.1016/s1051-0443(07)61791-6] [Cited by in Crossref: 69] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
77 Solmi L, Nigro G, Roda E. Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma. World J Gastroenterol 2006;12:1098-104. [PMID: 16534852 DOI: 10.3748/wjg.v12.i7.1098] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
78 Imajo K, Ogawa Y, Yoneda M, Saito S, Nakajima A. A review of conventional and newer generation microwave ablation systems for hepatocellular carcinoma.J Med Ultrason (2001). 2020;47:265-277. [PMID: 31960190 DOI: 10.1007/s10396-019-00997-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Yu D, Meyer T, Patch DW, Burroughs AK. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev. 2006;32:594-606. [PMID: 17045407 DOI: 10.1016/j.ctrv.2006.08.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]